Pemphigus foliaceus antigen: Characterization of an immunoreactive tryptic fragment from BALBc mouse epidermis recognized by all patients' sera and major autoantibody subclasses
Clinical Immunology and Immunopathology, ISSN: 0090-1229, Vol: 57, Issue: 2, Page: 317-329
1990
- 17Citations
- 5Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations17
- Citation Indexes17
- 17
- CrossRef15
- Captures5
- Readers5
Article Description
The pemphigus foliaceus antigen (PF Ag) is a 160-kDa desmosomal core glycoprotein, desmoglein I. A 50-kDa soluble immunoreactive fragment of the PF Ag was recently prepared from trypsinized cornified cell envelope preparations by papain treatment (R. S. Labib et al. 1989, J. Invest. Dermatol. 93, 272–279). This papain fragment (pf-PF) is associated with upper cell layers of the epidermis and appears to be trypsin resistant in situ. The present work describes the preparation of another fragment by trysinization of the viable lower cells of the epidermis of neonatal BALBc mice. This tryptic fragment (tf-PF) is a 45-kDa glycoprotein that is partially purified by concanavalin A affinity chromatography of the trypsinization medium. The partially purified tf-PF preparation is capable of completely blocking the indirect immunofluorescence of high titer PF sera. The tf-PF is immunoprecipitated by all PF sera tested ( n = 19) and by the two major subclasses of PF autoantibodies, IgG1 and IgG4. Autoantibodies of both the predominant IgG4 and the less prevalent IgG1 subclasses precipitate the same tf-PF as demonstrated by a single compact spot of p I 5.5 by two-dimensional polyacrylamide gel electrophoresis. Chemical and immunological comparison of the tf-PF and pf-PF may explain why the acantholytic lesions of PF appear only in the upper epidermis, despite the presence of the PF Ag throughout all layers of the epidermis. The availability of these two soluble immunoreactive fragments of the PF Ag will be of great value for the further immunochemical characterization of the antigenic epitopes and their role in cell-cell adhesion.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/009012299090045R; http://dx.doi.org/10.1016/0090-1229(90)90045-r; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0025153837&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/2208810; https://linkinghub.elsevier.com/retrieve/pii/009012299090045R; http://linkinghub.elsevier.com/retrieve/pii/009012299090045R; http://api.elsevier.com/content/article/PII:009012299090045R?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:009012299090045R?httpAccept=text/plain; http://dx.doi.org/10.1016/0090-1229%2890%2990045-r; https://dx.doi.org/10.1016/0090-1229%2890%2990045-r
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know